MSFT

MSFT Common Stock Issued

$2.01BTTM · USD

Period ending:

MSFT FY Common Stock IssuedUSD
MSFT FY Common Stock Issued1989-06-30: $6.30M1990-06-30: $109.80M1991-06-30: $179.70M1992-06-30: $265.10M1993-06-30: $436.00M1994-06-30: $431.00M1995-06-30: $332.00M1996-06-30: $504.00M1997-06-30: $1.82B1998-06-30: $1.50B1999-06-30: $2.12B2000-06-30: $2.72B2001-06-30: $1.62B2002-06-30: $1.50B2003-06-30: $2.12B2004-06-30: $2.75B2005-06-30: $3.11B2006-06-30: $2.10B2007-06-30: $6.78B2008-06-30: $3.49B2009-06-30: $579.00M2010-06-30: $2.31B2011-06-30: $2.42B2012-06-30: $1.91B2013-06-30: $931.00M2014-06-30: $607.00M2015-06-30: $634.00M2016-06-30: $668.00M2017-06-30: $772.00M2018-06-30: $1.00B2019-06-30: $1.14B2020-06-30: $1.34B2021-06-30: $1.69B2022-06-30: $1.84B2023-06-30: $1.87B2024-06-30: $2.00B2025-06-30: $2.06B2026-06-30: $2.01B$6.78B$0.00
1989-06-302026-06-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MSFT common stock issued history

Cash received from issuing common stock. The available annual fiscal periods series contains 38 observations from Jun 30, 1989 to Jun 30, 2026.

Microsoft Common Stock Issued — Annual fiscal periods (USD)
Period endingCommon Stock Issued (USD)
2,009,000,000
2,056,000,000
2,002,000,000
1,866,000,000
1,841,000,000
1,693,000,000
1,343,000,000
1,142,000,000
1,002,000,000
772,000,000
668,000,000
634,000,000
607,000,000
931,000,000
1,913,000,000
2,422,000,000
2,311,000,000
579,000,000
3,494,000,000
6,782,000,000
2,101,000,000
3,109,000,000
2,748,000,000
2,120,000,000
1,497,000,000
1,620,000,000
2,717,000,000
2,116,000,000
1,497,000,000
1,819,000,000
504,000,000
332,000,000
431,000,000
436,000,000
265,100,000
179,700,000
109,800,000
6,300,000

Compare common stock issued

All MSFT financial metrics · MSFT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.